Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuko Harada

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
American Journal of Clinical Pathology|June 2, 2021
NAB2-STAT6 Gene Fusions to Evaluate Primary/Metastasis of Hemangiopericytoma/Solitary Fibrous TumorsNirupama Singh, Robin Collingwood, Marie-Lisa Eich, et al.
American Journal of Clinical Pathology|March 21, 2019
Effects of Improved DNA Integrity by Punch From Tissue Blocks as Compared to Pinpoint Extraction From Unstained Slides on Next-Generation Sequencing Quality MetricsDiana Morlote, Karen M Janowski, Rance C Siniard, et al.
The American Journal of Surgical Pathology|July 11, 2024
Inflammatory Giant Cell Carcinoma of the Lung: Clinicopathologic, Immunohistochemical, and Next-generation Sequencing Study of 14 CasesDavid I Suster, A Craig Mackinnon, Natali Ronen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2015
Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional StudyXiaojun Wu, Joong Won Lee, Deniz Peker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
First-Line Treatment of Widely Metastatic <i>BRAF</i>-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK InhibitionVictor T G Lin, Lisle M Nabell, Sharon A Spencer, et al.
Human Pathology|August 8, 2025
Association between p16<sup>INK4A</sup> expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinomaXiao Huang, Shuko Harada, Shi Wei, et al.
Cancer Cytopathology|May 9, 2015
Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processingShuko Harada, Emmanuel Agosto-Arroyo, Jessica A Levesque, et al.
Breast Cancer Research and Treatment|June 20, 2024
p53 protein expression patterns associated with TP53 mutations in breast carcinomaSarah A Anderson, Brooke B Bartow, Shuko Harada, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 18, 2011
Analysis of hematopoietic stem cell transplant engraftment: use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancyMing-Tseh Lin, Li-Hui Tseng, Katie Beierl, et al.
International Journal of Surgical Pathology|April 28, 2022
Spindle Cell Sarcoma of the Uterus Harboring <i>MEIS1::NCOA1</i> Fusion Gene and Mimicking Endometrial Stromal SarcomaHaider A Mejbel, Shuko Harada, Todd M Stevens, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Pathology|June 2, 2021
NAB2-STAT6 Gene Fusions to Evaluate Primary/Metastasis of Hemangiopericytoma/Solitary Fibrous TumorsNirupama Singh, Robin Collingwood, Marie-Lisa Eich, et al.
American Journal of Clinical Pathology|March 21, 2019
Effects of Improved DNA Integrity by Punch From Tissue Blocks as Compared to Pinpoint Extraction From Unstained Slides on Next-Generation Sequencing Quality MetricsDiana Morlote, Karen M Janowski, Rance C Siniard, et al.
The American Journal of Surgical Pathology|July 11, 2024
Inflammatory Giant Cell Carcinoma of the Lung: Clinicopathologic, Immunohistochemical, and Next-generation Sequencing Study of 14 CasesDavid I Suster, A Craig Mackinnon, Natali Ronen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2015
Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional StudyXiaojun Wu, Joong Won Lee, Deniz Peker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
First-Line Treatment of Widely Metastatic <i>BRAF</i>-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK InhibitionVictor T G Lin, Lisle M Nabell, Sharon A Spencer, et al.
Human Pathology|August 8, 2025
Association between p16<sup>INK4A</sup> expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinomaXiao Huang, Shuko Harada, Shi Wei, et al.
Cancer Cytopathology|May 9, 2015
Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processingShuko Harada, Emmanuel Agosto-Arroyo, Jessica A Levesque, et al.
Breast Cancer Research and Treatment|June 20, 2024
p53 protein expression patterns associated with TP53 mutations in breast carcinomaSarah A Anderson, Brooke B Bartow, Shuko Harada, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 18, 2011
Analysis of hematopoietic stem cell transplant engraftment: use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancyMing-Tseh Lin, Li-Hui Tseng, Katie Beierl, et al.
International Journal of Surgical Pathology|April 28, 2022
Spindle Cell Sarcoma of the Uterus Harboring <i>MEIS1::NCOA1</i> Fusion Gene and Mimicking Endometrial Stromal SarcomaHaider A Mejbel, Shuko Harada, Todd M Stevens, et al.
Pageof 9